331. 特発性多中心性キャッスルマン病 Idiopathic multicentric castleman disease Clinical trials / Disease details

臨床試験数 : 33 / 薬物数 : 41 - (DrugBank : 21) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 123

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01441063 (ClinicalTrials.gov)	September 13, 2011	24/9/2011	Tocilizumab for KSHV-Associated Multicentric Castleman Disease	Pilot Study of Tocilizumab in Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV) - Associat ...	Castleman Disease;Multicentric Castleman Disease;Giant Lymph Node Hyperplasia	Drug: Zidovudine;Drug: Tocilizumab;Drug: Valganciclovir (VGC)	National Cancer Institute (NCI)	NULL	Completed	18 Years	N/A	All	8	Phase 2	United States
2	NCT00361933 (ClinicalTrials.gov)	December 2008	8/8/2006	Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease	Clinical and Virologic Response to HHV-8 Associated Multicentric Castleman's Disease to Valganciclov ...	Giant Lymph Node Hyperplasia	Drug: Valganciclovir	University of Washington	Hoffmann-La Roche	Withdrawn	18 Years	N/A	All	0	Phase 4	United States
3	NCT00092222 (ClinicalTrials.gov)	October 28, 2004	21/9/2004	Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Corr ...	Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's ...	Lymphoproliferative Disorder;HHV-8;Malignancy;HIV	Drug: Etoposide;Drug: Interferon-alpha;Drug: Rituximab;Drug: Zidovudine;Drug: Liposomal Doxorubicin; ...	National Cancer Institute (NCI)	NULL	Active, not recruiting	18 Years	N/A	All	75	Phase 2	United States

First Previous1Next Last